Garry A. Neil

Gastroenterology

116 Muirfield Ct
New Hope, PA 18938

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Realigning the LIGHT signaling network to control dysregulated inflammation.

Realigning the LIGHT signaling network to control dysregulated inflammation.

Journal: The Journal of experimental medicine

Published: February 25, 2022

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.

Journal: The Journal of clinical investigation

Published: July 16, 2021

Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.

Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.

Journal: mSphere

Published: August 21, 2020

Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.

Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.

Journal: Blood

Published: December 26, 2019

Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases.

Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 08, 2018

Sustained intrathecal therapeutic protein delivery using genetically transduced tissue implants in a freely moving rat model.

Sustained intrathecal therapeutic protein delivery using genetically transduced tissue implants in a freely moving rat model.

Journal: International journal of pharmaceutics

Published: June 26, 2017

Sustained secretion of anti-tumor necrosis factor α monoclonal antibody from ex vivo genetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis.

Sustained secretion of anti-tumor necrosis factor α monoclonal antibody from ex vivo genetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis.

Journal: The journal of gene medicine

Published: April 03, 2017

TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal Disease.

TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal Disease.

Journal: The New England journal of medicine

Published: January 12, 2017

Preclinical and Preliminary Clinical Evaluation of Genetically Transduced Dermal Tissue Implants for the Sustained Secretion of Erythropoietin and Interferon α.

Preclinical and Preliminary Clinical Evaluation of Genetically Transduced Dermal Tissue Implants for the Sustained Secretion of Erythropoietin and Interferon α.

Journal: Human gene therapy. Clinical development

Published: December 20, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026